Impact of Robotic Cochlear Implantation on Hearing Performance in Noise
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Surgery with RobOtol®, Conventional manual surgery.
- Who it may be relevant to
- Registry conditions: Severe to Profound Hearing Loss. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this study is to compare two methods of cochlear implantation : conventional manual insertion versus robot-assisted in order to verify whether robotic insertion provides better performance in the noisy environment. To do this, we will compare the two methods of insertion of the electrode holder, on 140 patients candidates for cochlear implantation randomized in two groups (70 conventional surgery versus 70 robot-assisted surgery). All patients will be recruited during 17 months, in our Ear, nose and throat (ENT) Department of the Pitié-Salpêtrière hospital group, the first center for adult patients established in France (on average 180 patients/year). Patient will be followed for 9 months with clinical evaluation, imaging, audiometric, listening effort and quality of life assessments. These evaluations will be carried out preoperatively and postoperatively at 3 months and 6 months post-activation of the cochlear implant.
Detailed description
In the case of severe (70 to 90dB loss) and profound (\>90dB loss) hearing loss, when conventional hearing aids no longer provide sufficient benefit, cochlear implantation remains the only possible solution for hearing rehabilitation. In implanted patients, a clear improvement in communication in silence is observed, but almost all patients have difficulty understanding speech in noisy environments. Cochlear implantation involves inserting an electrode holder into the cochlea during a surgical procedure under general anesthesia. The insertion of the electrode holder must be as minimally traumatic as possible in order to preserve the cochlear structures and avoid post-operative fibrosis that could impact the auditory outcomes.
The conventional method of this surgery is the manual insertion of the electrode holder. In recent years, robotic assistance, the RobOtol®, has been developed with the aim of avoiding the jerks of the surgeon's hand and improving the precision of the insertion. RobOtol® has had its CE marking since 2016 and is used in several hospitals in France and abroad.
Interventions
- Procedure Surgery with RobOtol®
Patient having cochlear implantation surgery with RobOtol®. - Procedure Conventional manual surgery
Patient having conventional manual cochlear implantation surgery
Primary outcome measures
- Auditory performance in noise with the cochlear implant [Time frame: At 6 months post-implantation]
Secondary outcome measures (12)
- Hearing performance in noise after robotic cochlear implantation compared to conventional manual cochlear implantation for phonemes [Time frame: At 3 and 6 months post-implantation]
- Hearing performance in noise under ecological conditions after robotic cochlear implantation compared to conventional manual cochlear implantation [Time frame: At 3 and 6 months post-implantation]
- Hearing performance in silence after robotic cochlear implantation compared to conventional manual cochlear implantation for words [Time frame: At 3 and 6 months post-implantation]
- Hearing performance in silence after robotic cochlear implantation compared to conventional manual cochlear implantation for phonemes [Time frame: At 3 and 6 months post-implantation]
- The subjective benefit on tinnitus after robotic cochlear implantation compared to conventional manual cochlear implantation [Time frame: At 3 and 6 months post-implantation]
- The subjective benefit on quality of life after robotic cochlear implantation compared to conventional manual cochlear implantation [Time frame: At 3 and 6 months post-implantation]
- The position of the electrode array in the cochlea during manual and robotic insertions [Time frame: At day one post -implantation]
- The impact of a translocation on auditory performance in silence and in noise [Time frame: At 3 and 6 months post-implantation]
- The effort of listening in silence and in noise after manual and robotic insertions assessed with the Speech, Spatial and Qualities of Hearing Scale (SSQ) [Time frame: At 3 and 6 months post-implantation]
- The effort of listening in silence and in noise after manual and robotic insertions assessed with a visual analog scale [Time frame: At 3 and 6 months post-implantation]
- The preservation of residual hearing after cochlear implantation in cases with residual hearing before surgery [Time frame: At 30 days, 3 months and 6 months post-implantation]
- The presence of postoperative vertigo in case of robotic cochlear implantation compared to manual implantation [Time frame: At 7 days, 3 months and 6 months post-implantation]
Eligibility criteria
Inclusion criteria
- Adult patient ≥ 18 years old
- Patients with an indication for uni or bilateral, simultaneous or sequential cochlear implantation: severe to profound bilateral deafness with intelligibility ≤70% for Fournier dissyllabic words, in free field, at 60dB with adapted hearing aids.
- Patient able to understand the information note and give written consent
- Affiliation to a French social security system
Exclusion criteria
- Patient who does not speak French
- Etiologies of deafness known to be of bad prognosis (auditory neuropathy, congenital profound deafness, immediate post-meningitis profound deafness, vestibular schwannoma on the side of the ear to be implanted)
- Impossibility of testing the effect of the cochlear implant alone on hearing results (cochlear implantation in the context of unilateral deafness or fluctuating deafness)
- Cochlear implantation requiring the use of a perimodiolar electrode holder.
- Pregnant and breastfeeding women
- Patients wearing electronic devices, in direct connection with the brain or nervous system
- Patient included in another interventional study (Jardé 1)
- Patient under legal protection (guardianship or curatorship) or deprived of liberty
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Other
Study locations
France · 1 center
- Groupe Hospitalier Pitié-Salpêtrière — Paris
Identifiers
NCT: NCT06248398 · APHP211330 · 2023-A00837-38